The drug, Olmesartan Medoxomil and its combination products marketed under the brand name Benitec, is currently available in over 50 countries with an annual sales of $2 billion. Olmesartan is an original research patented product of Daiichii Sankyo.
"Our strategy of in- licensing products in specific high growth therapeutic areas is being rolled out and is well on track, "said Hasit Joshipura, Managing Director, GSK India.
Last week, GSK Pharma had signed another collaboration agreement with Japan's Astellas Pharma Inc for exclusive rights to distribute an injectable anti-fungal drug micafungin, sold under the brand name Mycamine, in the Indian market.
Hasit Joshipura had told Business Standard in February this year that the company would inlicense two drugs from overseas companies and launch a rotavirus vaccine and the breast cancer drug Tykerb from its parent stable, within the second quarter of this year.